- Home
- Companies
- us virgin islands
- stem stromal cells
Refine by
Stem Stromal Cells Suppliers Serving Us Virgin Islands
139 companies found
based inArden, NORTH CAROLINA (USA)
Akuratemp designs and manufactures temperature-controlled packaging to keep life science products within acceptable temperature ranges during transportation. A leading temperature-controlled packaging solution for healthcare with advanced phase ...
based inLugano, SWITZERLAND
healiva® is a patient centric Swiss Biotech company, delivering precision medicine to improve patients’ quality of life. We use a multi-pronged approach to address patient needs by combining enzyme technology, medical devices, and cell therapy to ...
based inMeyzieu, FRANCE
CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in ...
Although much is known about the appearance, growth and spread of cancer in the human body, effective and rapid treatments for many cancer types are yet to be found. Chemo- and radio- therapies have made much progress in the last 20 years, but ...
based inLeopoldshöhe, GERMANY
Barkey is a German, globally active family business in its second generation, specializing in medical technology in the field of warming devices with a clear goal: prevention of hypothermia. Barkey GmbH & Co. KG was founded in 1980 by Volker I. ...
The Barkey plasmatherm is the innovative and user-friendly solution for warming standard blood and plasma bags. The patented heat technology allows dry warming and thawing of Fresh Frozen Plasma (FFP), erythrocyte concentrates (EK) as well as ...
based inBangkok, THAILAND
The Regeneration Center provides comprehensive and scientifically backed stem cell treatments for numerous conditions and degenerative diseases. Through years of research and clinical applications of modern cellular therapeutics our internationally ...
For thousands of years now, various cultures around the world have developed unique practices to promote physical healing and wellness therapies that would be known as integrative medicine. These ancient and traditional approaches to healthcare have ...
based inHolliston, MASSACHUSETTS (USA)
HRGN is a clinical-stage biotechnology company that uses a patient’s own stem cells that are grown on a hollow tubular scaffold to regenerate organ tissue damaged from cancer, trauma, birth defects or other diseases. The patient’s stem ...
Following extensive research and development, Biostage has evolved its technology to optimize the interaction of mesenchymal stem cells seeded on a biocompatible scaffold. Preclinical studies suggest that, once implanted, the scaffold seeded with ...
based inHouston, TEXAS (USA)
InGeneron believes that evidence-based regenerative therapy will redefine the health care experience. Our system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative ...
InGeneron’s proprietary MatraseTM Reagent is a high purity enzymatic mixture for the release of mesenchymal stem cells and other regenerative cells from adipose tissue. The product is manufactured under a contract by a major biopharmaceutical ...
based inSunrise, FLORIDA (USA)
U.S. Stem Cell, Inc. (OTC:USRM) is an emerging leader in the worldwide development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions. Based in Sunrise, Florida, the Company has developed a clinical ...
U.S. Stem Cell’s lead product candidate is MyoCell®, a muscle stem cell therapy that is intended to improve cardiac function months or even years after a patient has suffered severe heart damage due to a heart attack. The procedure ...
based inMadison, WISCONSIN (USA)
InvivoSciences, Inc. (IVS) is a precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered microtissues. Our unique integration of cell & tissue ...
based inWoburn, MASSACHUSETTS (USA)
Aegle Therapeutics is a first in class, phase 1/2a stage biotechnology company isolating extracellular vesicles including exosomes (EVs) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa ...
Epidermolysis bullosa (“EB”) is a group of rare genetic disorders that manifests as blistering or erosion of the skin in response to little or no apparent trauma. There are many genetic and symptomatic variations of EB. EB is always ...
based inMont-Saint-Guibert, BELGIUM
Novadip is transforming the lives of patients using its unique 3M3 tissue regeneration technology platform. Based on the scientific discoveries of Prof. Dr. Denis Dufrane, Novadip is a spin-off company from Université Catholique de Louvain ...
Novadip’s unique “3M3” platform for tissue regeneration combines over 15 years of academic research with practical surgery experience and proof of principle clinical data. ...
based inWaltham, MASSACHUSETTS (USA)
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid ...
based inSugar Land, TEXAS (USA)
Our mission is to develop and deliver adult stem cell solutions that are safe, effective and affordable for incurable conditions. Our vision is a world where stem cells are regularly used to not only treat disease but prevent it. Today, medicine is ...
This may seem like a silly question but the truth is that almost everyone that has banked their stem cells has banked for the purpose of banking rather than for the purpose of using. Most banking services simply bank tissues that contain stem cells. ...
based inMannheim, GERMANY
faCellitate is a venture that originated from BASF’s incubator, Chemovator, and it provides interactive consumables for advanced cell technologies and regenerative medicine in the 3D cell culture market. Its unique polymeric platform aims at ...
based inNew Albany, INDIANA (USA)
Tissue Genesis, LLC offers best-in-class, clinical-grade cell therapy solutions. Its state-of-the-art Icellator® X is a high-performance, point-of-care device that efficiently extracts adult stem cells from a small sample of autologous adipose ...
The Icellator2 system set the standard, providing SVF cell yields in 65 minutes. Currently approved for use in The Bahamas and available in Japan. In the USA, clinical FDA-approved IDE studies using the Icellator® are underway for a variety of ...
based inJena, GERMANY
We develop, manufacture and sell high-quality automated solutions for life sciences in a broad range of areas including molecular diagnostics, cancer and stem cell research, cell line development and bioprocessing. Our core competencies are in ...
The semi-solid media module was specifically developed for the isolation of bacteria and cell colonies as well as 3D clones from semi-solid and solid media (e.g. methylcellulose, matrigel, ...
based inGangnam-gu, SOUTH KOREA
MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our ...
MIT-001 is an innovative clinical candidate that blocks the root cause of graft-versus-host disease, which often occurs during allogenic hematopoietic stem cell transplantation (HSCT), through a mechanism of action that is differentiated from any ...
based inLakewood, NEW JERSEY (USA)
We are an ISO9001 Certified manufacturer of enzymes and biochemicals for life science research, primary and stem cell isolation, bioprocessing, biopharma, diagnostics and biotechnology applications. Backed by over 75 years of expertise, we maintain ...
based inWashington, DISTRICT OF COLUMBIA (USA)
The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM promotes legislative, regulatory, reimbursement and ...
based inCalgary, ALBERTA (CANADA)
Hemostemix (TSX V:HEM; OTCQB:HMTXF) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. Hemostemix’s proprietary platform technology is based on more ...
Hemostemix’s technology uses a patient’s own cells to treat that patient’s disease. The cornerstone of this autologous technology is a novel cell population within the blood called the synergetic cell population (SCP). The ...